As of Feb 17
| -0.075 / -1.33%|
The 2 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00. The median estimate represents a +170.27% increase from the last price of 5.55.
The current consensus among 1 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.